News FDA Restricts Authorization of Janssen’s COVID-19 Vaccine May 5, 2022 Read More » Enhertu Obtains Regular FDA Approval After Accelerated Approval May 4, 2022 Read More » Voquezna Approved to Treat Common Cause of Stomach Ulcers May 4, 2022 Read More » FDA Approves First Nonstimulant ADHD Drug for Adults in 20 Years May 2, 2022 Read More » Cuvrior Approved for Life-Threatening Genetic Disorder May 2, 2022 Read More » First Therapeutically Equivalent Velcade Generics Approved May 2, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in May May 1, 2022 Read More » Rinvoq Now Indicated for Ankylosing Spondylitis April 29, 2022 Read More » Ultomiris Granted New Myasthenia Gravis Indication April 28, 2022 Read More » Page1 … Page28 Page29 Page30 Page31 Page32 … Page38 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in May May 1, 2022 Read More »